Related Experiment Video
Updated: Jun 11, 2026
14:14
Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
Deep brain stimulation for dystonia: patient selection and outcomes
J D Speelman1, M F Contarino, P R Schuurman
1Departments of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
European Journal of Neurology
|July 2, 2010
Summary
Deep brain stimulation (DBS) of the globus pallidus (GPi) shows favorable outcomes for primary dystonias. While effective for some secondary dystonias, further research is needed to confirm GPi-DBS efficacy in these cases.
Area of Science:
- Neurology
- Neurosurgery
- Movement Disorders
Background:
- Dystonia is a complex movement disorder with primary and secondary forms.
- Deep brain stimulation (DBS) is a therapeutic option for managing dystonia.
- The internal segment of the globus pallidus (GPi) is a common target for DBS in dystonia.
Purpose of the Study:
- To evaluate the efficacy of GPi-DBS in patients with primary and secondary dystonias.
- To identify predictors of positive and negative outcomes following GPi-DBS.
- To assess the current evidence for GPi-DBS in different dystonia subtypes.
Main Methods:
- Literature survey of 341 patients with primary and 109 with secondary dystonias treated with GPi-DBS.
- Analysis of outcomes based on dystonia type (primary vs. secondary).
- Identification of factors influencing treatment success.
Main Results:
- Overall, GPi-DBS outcomes were more favorable for primary dystonias than secondary forms.
- Very good outcomes were observed for specific secondary dystonias: tardive dystonia, myoclonus-dystonia (M-D), and NBIA (PANK2).
- Randomized controlled trials have confirmed GPi-DBS efficacy only for primary generalized dystonias.
Conclusions:
- GPi-DBS is a promising treatment for dystonia, particularly primary forms.
- Patient selection, surgical team expertise, and post-operative care are crucial for successful outcomes.
- Further research is necessary to establish the definitive role of GPi-DBS in treating various secondary dystonias.
